Centrist US Lawmaker Announces Firm Opposition to Biden Safety Net Legislation

A centrist U.S. Democratic lawmaker, Senator Joe Manchin of West Virginia, said Sunday he is definitively opposed to President Joe Biden’s roughly $2 trillion social safety net spending plan, likely dooming its passage without further sharp revisions in its scope and cost. 

Manchin’s vote was essential in the politically divided Senate for passage of one of the key elements of the Democratic president’s legislative agenda. None of the 50 Republicans in the 100-member chamber supports the plan to expand health care for older Americans, provide universal pre-kindergarten classes, authorize new funding to combat climate change and offer more financial support for low-income Americans. 

Democrats had hoped to push through the legislation on a 51-50 vote before Christmas, with Vice President Kamala Harris providing the tie-breaking vote. The House of Representatives has already approved a version of the bill. 

But Manchin, who discussed the measure at length last week with Biden, told the “Fox News Sunday” show, “If I can’t go home and explain it to the people of West Virginia, I can’t vote for it. And I cannot vote to continue with this piece of legislation.” 

“I just can’t,” Manchin said. “I’ve tried everything humanly possible. I can’t get there. This is a ‘no’ on this legislation.” 

The White House said the lawmaker last week offered a framework for a compromise on the legislation and “promised to continue conversations in the days ahead, and to work with us to reach that common ground.” 

White House press secretary Jen Psaki said in a statement that if Manchin’s comments “indicate an end to that effort, they represent a sudden and inexplicable reversal in his position, and a breach of his commitments to the President and the Senator’s colleagues in the House and Senate.” 

She rebuffed Manchin’s claims that the legislation would add to the surge in consumer prices in the United States, the highest in nearly four decades, or add to the country’s long-term debt, now more than $29 trillion, because the new spending would be paid for with higher taxes on corporations and wealthy individuals.

One of the key Senate architects of the legislation, Senator Bernie Sanders of Vermont, reacted angrily to Manchin’s refusal to support fellow Democratic colleagues and vote for it. Sanders said Manchin “doesn’t have the guts” to take on special business interests who would be impacted most by the legislation.

Sanders told CNN’s “State of the Union” show he wants the Senate to vote on the measure anyway, even if it is headed to defeat, to force Manchin to publicly account for his vote. 

“He’s going to have a lot of explaining to do with the people of West Virginia,” Sanders said. “Let him vote ‘no’ and explain it to the world.” 

CNN Closes US Offices to Most Workers as COVID-19 Cases Spike

CNN is closing its offices in the United States to all nonessential employees as COVID-19 cases increase, the network said on Saturday in an internal memo to staff seen by Reuters.

CNN, part of AT&T Inc’s WarnerMedia division, will close its offices to all employees who do not have work in the office, the memo said.

“We are doing this out of an abundance of caution,” CNN President Jeff Zucker said in the memo. “And it will also protect those who will be in the office by minimizing the number of people who are there.”

Employees who need to come to the office will be required to wear a mask at all times, CNN said.

The network will also make changes to its studios and control rooms to minimize the number of people at offices, according to the memo.

The news was first reported by The Wall Street Journal.

The network had set a tentative return-to-office date in January and it isn’t known if that date will move, the Journal reported, citing a person familiar with the matter.

CNN requires all employees to be vaccinated against the COVID-19 to come to office or to work on field with other employees.

In August, the company terminated three of its workers for coming to the office unvaccinated.

 

 

Omicron Variant Spurs New Lockdown in Netherlands

“The Netherlands is shutting down again,” Prime Minister Mark Rutte said Saturday in a televised address. The new measures, beginning Sunday, Rutte said, are because of a “fifth wave” of COVID-19, due to the highly contagious omicron variant.

Under the new rules, all non-essential shops will be closed to at least mid-January. Only two guests will be permitted to visit a household at one time. Four guests, however, will be allowed during the upcoming holidays from Dec. 24-26 and New Year’s Eve and New Year’s Day.

Schools will be immediately closed until at least Jan. 9.

While the Netherland boasts an 85% inoculation rate of its population, only 9% have received booster shots.

Jaap van Dissel, the chief of the Dutch outbreak management team, said the shutdown will give people time to get their booster jabs and gives hospitals time to prepare for the possible surge in COVID cases.

Other European countries are also moving to reimpose restrictions to contain the variant’s spread.

The new variant has fueled infections in Britain close to the peak levels of early 2021, while other European countries and the United States are also experiencing surges.

Scientists are warning the British government needs to go further to prevent hospitals from being overwhelmed amid the surge. The warning comes after the government reimposed an indoor mask requirement and ordered people to show proof of vaccination or a recent negative coronavirus test when entering night clubs or large venues.

Britain’s Health Security Agency said Friday that 65 patients were hospitalized in England with omicron.

In France, the government said it would start inoculating children ages 5-11 beginning Wednesday. As he declared Friday the omicron variant was spreading like “lightning,” Prime Minister Jean Castex proposed requiring proof of vaccination for those entering public establishments.

The measure, which requires parliamentary approval, has triggered plans for protests Saturday in Paris, where the New Year’s Eve fireworks display has been canceled.

Anti-lockdown protests also are planned for Saturday in Turin, Italy.

 

Egypt has detected its first three cases of the new variant, according to the country’s health ministry. The ministry said Friday the three infected people were among 26 travelers who tested positive for coronavirus at Cairo International Airport.

The ministry did not say where the three came from, but the Masrawy news outlet reported they were among travelers from South Africa, which announced the discovery of the variant on Nov. 25.

In China, Beijing will maintain its relatively strict containment measures, while the rest of the country will remain flexible. “There is no one-fit-for-all policy” for local governments, a Chinese government said Saturday at a news conference.

China has identified two cases of the omicron variant and has mostly contained the spread of COVID-19 since it was first discovered in the central Chinese city of Wuhan in late 2019.

A recent study has found the risk of reinfection with omicron is more than five times higher compared to the delta variant, and it has shown no sign of causing milder symptoms.

“We find no evidence of omicron having different severity from delta,” said the study by Imperial College London. The study noted, however, that data on hospitalizations is still limited.

The study, conducted in England between Nov. 29 and Dec. 11, was based on 333,000 cases of infections involving different variants of the coronavirus.

More than 5.3 million people have died of COVID-19 globally since the coronavirus emerged two years ago, according to the Johns Hopkins University Coronavirus Resource Center.

Administering vaccines

The center reported more than 8.6 billion doses of vaccines had been administered worldwide as of midday Saturday, a massive logistical campaign complicated by omicron’s surge.

Several countries are racing to accelerate vaccination campaigns as mounting evidence supports the need for booster doses to combat the omicron variant.

Turkish President Recep Tayyip Erdogan said Saturday that his country would send 15 million doses of vaccines to Africa, where infections are surging and vaccination rates are low. Erdogan made the announcement at a summit of African leaders in Istanbul.

“It is disgraceful for humanity that only 6% of Africa’s population has been vaccinated,” Erdogan said.

A vaccine developed in India, Covovax, was granted emergency approval Friday by the World Health Organization. WHO vaccines chief Mariangela Simao said the approval “aims to increase access particularly to lower-income countries.”

In Europe, European Union governments agreed to order more than 180 million doses of a BioNTech-Pfizer vaccine adapted for omicron, the head of the European Commission said Friday.

Japan’s Prime Minister Fumio Kishida said Friday the government plans to accelerate booster shots to around 31 million vulnerable people. He also said he spoke Friday with Pfizer CEO Albert Bourla about oral treatments.

South Africa, which first identified the omicron variant, said Friday it would donate about 2 million doses of Johnson & Johnson’s vaccine to other African countries next year via a medical supplies platform established by the African Union.

Some information in this report came from Agence France-Presse, The Associated Press and Reuters. 

 

 

Ransomware Persists Even as High-Profile Attacks Have Slowed

In the months since President Joe Biden warned Russia’s Vladimir Putin that he needed to crack down on ransomware gangs in his country, there hasn’t been a massive attack like the one last May that resulted in gasoline shortages. But that’s small comfort to Ken Trzaska.

Trzaska is president of Lewis & Clark Community College, a small Illinois school that canceled classes for days after a ransomware attack last month that knocked critical computer systems offline.

“That first day,” Trzaska said, “I think all of us were probably up 20-plus hours, just moving through the process, trying to get our arms around what happened.”

Even if the United States isn’t currently enduring large-scale, front-page ransomware attacks on par with ones earlier this year that targeted the global meat supply or kept millions of Americans from filling their gas tanks, the problem hasn’t disappeared. In fact, the attack on Trzaska’s college was part of a barrage of lower-profile episodes that have upended the businesses, governments, schools and hospitals that were hit.

The college’s ordeal reflects the challenges the Biden administration faces in stamping out the threat — and its uneven progress in doing so since ransomware became an urgent national security problem last spring.

Smaller-scale attacks continue

U.S. officials have recaptured some ransom payments, cracked down on abuses of cryptocurrency, and made some arrests. Spy agencies have launched attacks against ransomware groups and the U.S. has pushed federal, state and local governments, as well as private industries, to boost protections.

Yet six months after Biden’s admonitions to Putin, it’s hard to tell whether hackers have eased up because of U.S. pressure. Smaller-scale attacks continue, with ransomware criminals continuing to operate from Russia with seeming impunity. Administration officials have given conflicting assessments about whether Russia’s behavior has changed since last summer. Further complicating matters, ransomware is no longer at the top of the U.S.-Russia agenda, with Washington focused on dissuading Putin from invading Ukraine.

The White House said it was determined to “fight all ransomware” through its various tools but that the government’s response depends on the severity of the attack.

“There are some that are law enforcement matters and others that are high impact, disruptive ransomware activity posing a direct national security threat that require other measures,” the White House statement said.

Ransomware attacks — in which hackers lock up victims’ data and demand exorbitant sums to return it — surfaced as a national security emergency for the administration after a May attack on Colonial Pipeline, which supplies nearly half the fuel consumed on the East Coast.

The attack prompted the company to halt operations, causing gas shortages for days, though it resumed service after paying more than $4 million in ransom. Soon after came an attack on meat processor JBS, which paid an $11 million ransom.

Biden met with Putin in June in Geneva, where he suggested critical infrastructure sectors should be “off limits” for ransomware and said the U.S. should know in six months to a year “whether we have a cybersecurity arrangement that begins to bring some order.”

He reiterated the message in July, days after a major attack on a software company, Kaseya, that affected hundreds of businesses, and said he expected Russia to take action on cybercriminals when the U.S. provides enough information to do so.

Since then, there have been some notable attacks from groups believed to be based in Russia, including against Sinclair Broadcast Group and the National Rifle Association, but none of the same consequence or impact of those from last spring or summer.

‘Whole-of government’ effort

One reason may be increased U.S. government scrutiny, or fear of it.

The Biden administration in September sanctioned a Russia-based virtual currency exchange that officials say helped ransomware gangs launder funds. Last month, the Justice Department unsealed charges against a suspected Ukrainian ransomware operator who was arrested in Poland and has recovered millions of dollars in ransom payments. Gen. Paul Nakasone, the head of U.S. Cyber Command, told The New York Times his agency has begun offensive operations against ransomware groups. The White House says that “whole-of-government” effort will continue.

“I think the ransomware folks, the ones conducting them, are stepping back like, ‘Hey, if we do that, that’s going to get the United States government coming after us offensively,'” Kevin Powers, security strategy adviser for cyber risk firm CyberSaint, said of attacks against critical infrastructure.

U.S. officials, meanwhile, have shared a small number of names of suspected ransomware operators with Russian officials, who have said they have started investigating, according to two people familiar with the matter who were not authorized to speak publicly.

It’s unclear what Russia will do with those names, though Kremlin spokesperson Dmitry Peskov insisted the countries have been having a useful dialogue and said “a working mechanism has been established and is actually functioning.”

It’s also hard to measure the impact of individual arrests on the overall threat. Even as the suspected ransomware hacker awaits extradition to the U.S. following his arrest in Poland, another who was indicted by federal prosecutors was later reported by a British tabloid to be living comfortably in Russia and driving luxury cars.

Some are skeptical about attributing any drop-off in high-profile attacks to U.S. efforts.

“It could have just been a fluke,” said Dmitri Alperovitch, former chief technology officer of the cybersecurity firm Crowdstrike. He said asking Russia to crack down on large-scale attacks won’t work because “it’s way too granular of a request to calibrate criminal activity they don’t even fully control.”

Top American officials have given conflicting answers about ransomware trends since Biden’s discussions with Putin. Some FBI and Justice Department officials say they’ve seen no change in Russian behavior. National Cyber Director Chris Inglis said there’s been a discernible decrease in attacks but that it was too soon to say why.

It’s hard to quantify the number of attacks given the lack of baseline information and uneven reporting from victims, though the absence of disruptive incidents is an important marker for a White House trying to focus its attention on the most significant national security risks and catastrophic breaches.

Victims of ransomware attacks in the past few months have included hospitals, small businesses, colleges like Howard University — which briefly took many of its systems offline after discovering a September attack — and Virginia’s Legislature.

Not if, but when

The attack at Lewis & Clark, in Godfrey, Illinois, was discovered two days before Thanksgiving when the school’s IT director detected suspicious activity and proactively took systems offline, said Trzaska, the president.

A ransom note from hackers demanded a payment, though Trzaska declined to reveal the sum or identify the culprits. Though many attacks come from hackers in Russia or Eastern Europe, some originate elsewhere.

With vital education systems affected, including email and the school’s online learning platform, administrators canceled classes for days after the Thanksgiving break and communicated updates to students via social media and through a public alert system.

The college, which had backups on the majority of its servers, resumed operations this month.

The ordeal was daunting enough to inspire Trzaska and another college president who he says endured a similar experience to plan a cybersecurity panel.

“The stock quote from everyone,” Trzaska said, “is, ‘Not if it’s going to happen, but when it’s going to happen.’” 

US Workplace Vaccine Mandate Penalties to Start Jan. 10

The Occupational Health and Safety Administration said Saturday that it would not issue citations tied to its coronavirus vaccination mandate before Jan. 10, so that companies have time to adjust to and implement the requirements.

The federal agency separately said there would be no citations of companies regarding its testing requirements before Feb. 9.

The announcement came after the U.S. Court of Appeals for the Sixth District in Cincinnati decided on Friday that the mandate for large employers could go forward, reversing a previous court decision made after 27 Republican-led states, conservative groups, business associations and some individual companies challenged the mandate.

OSHA said in a statement that it would not issue citations before the listed dates “so long as an employer is exercising reasonable, good faith efforts to come into compliance with the standard.”

The mandate was previously slated to take effect Jan. 4.

The Biden administration’s vaccine requirement applies to companies with 100 or more employees and covers about 84 million U.S. workers. Employees who are not fully vaccinated have to wear face masks and be subject to weekly COVID-19 tests. There are exceptions, including for those who work outdoors or only at home.

Administration officials estimate that the mandate will save 6,500 lives and prevent 250,000 hospitalizations over six months. 

Egypt Announces its First Cases of Omicron Variant

Egyptian health authorities said they have identified the country’s first cases of the highly transmissible omicron variant of the coronavirus.

Three people were found to have the variant among 26 travelers who tested positive for coronavirus at Cairo International Airport, the Health Ministry said in a statement late Friday. It didn’t say where the three came from.

The local Masrawy news outlet reported the three were among travelers from South Africa.

The ministry said two of the people infected showed no symptoms, while the third suffered from mild symptoms. The three have been isolated in a Cairo hospital, it said.

Authorities on Friday reported more than 900 confirmed new cases of coronavirus and 43 deaths over the previous 24 hours.

Egypt has reported a total 373,500 cases, including 21,277 fatalities, since the pandemic began. 

 

WHO Chief: Inequitable Vaccine Distribution is ‘Failure for Humanity’

The head of the World Health Organization says the continuing surge of COVID-19 cases is a result of the unequal distribution of vaccines.

Speaking at the First International Conference on Public Health in Africa, WHO Director-General Tedros Adhanom Ghebreyesus noted that it has been just over a year since the first COVID-19 vaccines began to be administered.

He said, “A year ago, we all hoped that by now vaccines would be helping us all emerge from the long, dark tunnel of the pandemic. Instead, as we enter the third year of the pandemic, the death toll has more than tripled, and the world remains in its grip. COVID-19 has now killed more than 5 million people. And they’re just the reported deaths.”

Tedros told the virtual conference that the rapid development of not one, but several safe and effective vaccines, is a triumph of science. But he said, “the inequitable distribution of vaccines has been a failure for humanity.”

The WHO chief said that while more than 8.5 billion doses have been administered globally – the largest vaccination campaign in history, only 8% of Africa’s eligible population is fully vaccinated.

“We have often said that as long as vaccine inequity persists, the more opportunity the virus has to spread and mutate in ways no one can prevent or predict. And so, we have omicron,” the director-general said.

Tedros noted, however, that vaccine-sharing programs are “picking up speed.” He said, “In the past 10 weeks, COVAX has shipped more vaccines than in the first nine months of the year combined.”

 

Pandemic Could Extend To 2024, Pfizer Says

Pfizer Inc on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2- to 4-year-olds generated a weaker immune response than expected, potentially delaying authorization.

Pfizer Chief Scientific Officer Mikael Dolsten said in a presentation to investors that the company expects some regions to continue to see pandemic levels of COVID-19 cases over the next year or two. Other countries will transition to “endemic” with low, manageable caseloads during that same time period.

By 2024, the disease should be endemic around the globe, the company projected.

“When and how exactly this happens will depend on evolution of the disease, how effectively society deploys vaccines and treatments, and equitable distribution to places where vaccination rates are low,” Dolsten said. “The emergence of new variants could also impact how the pandemic continues to play out.”

Pfizer developed its COVID-19 vaccine with Germany’s BioNTech SE, and currently expects it to generate revenue of $31 billion next year. It plans to make 4 billion shots next year.

The drugmaker also has an experimental antiviral pill called Paxlovid which reduced hospitalizations and deaths in high-risk individuals by nearly 90% in a clinical trial.

Three analysts estimate sales of $15 billion to $25 billion for it next year, according to IBES data from Refinitiv.

Pfizer’s forecast came after the emergence of the omicron variant last month, which has more than 50 mutations compared with the original version of the virus. That has reduced the effectiveness of two doses of the vaccine against infection, and spurred fear of rapid spread around the globe.

Prior to the omicron variant, top U.S. disease doctor Anthony Fauci forecast the pandemic would end in 2022 in the United States.

Pediatric vaccine

The Pfizer vaccine is authorized in the United States for people aged 5 and older. But it said on Friday that its study in children between the ages of 2 and 4 who were given two 3-microgram doses of the vaccine found it did not create the same immune response that a larger dose of the vaccine had in older children.

The 3-microgram dose did generate a similar immune response in children aged 6 to 24 months, the company said. The company said it will now test a three-dose course in both age groups, as well as in older children. It had previously expected data from 2- to 4-year-olds this year but said it did not expect the delay would meaningfully change plans to file for emergency use authorization in the second quarter of 2022.

Pfizer and BioNTech have also been developing a version of their vaccine tailored to combat the quick-spreading omicron variant, although they have not decided whether it will be needed. They expect to start a clinical trial for the updated vaccine in January, Pfizer executives said.

Variant-specific shots, if needed, could boost sales in 2022. The highly transmissible omicron variant of the coronavirus has been det

ected in over 77 countries and has spread to about one-third of U.S. states.The vaccine was around 95% effective in the adult clinical trial, but Pfizer has said that immunity wanes some months after the second dose. Early data suggests that three doses of the shot may be necessary to protect against the omicron variant. 

 

US CDC Recommends ‘Test-to-Stay’ COVID-19 Options to Keep Kids in School 

The U.S. Centers for Disease Control and Prevention on Friday issued guidelines for keeping children in school even if they are unvaccinated or partially vaccinated and have been exposed to someone with COVID-19.

During a virtual briefing by the White House COVID-19 response team, CDC Director Rochelle Walensky said the test-to-stay protocol involves testing twice in a seven-day period anyone who has had close contact with someone infected with COVID-19. She said if exposed children meet certain criteria and continue to test negative, they can stay in school instead of quarantining at home.

Walensky said numerous jurisdictions have been experimenting with test-to-stay strategies. Some were testing every day, some every other day, and some twice a week. From those experiments, she said, the CDC will recommend no less than twice-weekly testing to adequately adhere to test-to-stay protocols.

The CDC also published studies conducted in the United States and internationally that looked at how COVID-19 is spread in schools, which helped form the basis for test-to-stay recommendations.

Walensky reported at least 39 U.S. states have more than 75 confirmed cases involving the omicron variant. She said the delta variant continues to circulate widely and remains the dominant strain in the United States, but omicron is spreading rapidly and is expected to become the dominant strain in the coming weeks.

The CDC director said omicron has been found among those who are vaccinated and boosted, and health officials believe these cases are milder or asymptomatic because of vaccine protection. “What we do know is we have the tools to protect ourselves against COVID-19,” she said.

White House Coronavirus Response Coordinator Jeff Zients said the U.S. is fully prepared to confront the variant, with ample supplies of vaccines and boosters.

“This is not a moment to panic, because we know how to protect people,” Zients said. “And we have the tools to do it.”

Some information for this report came from The Associated Press and Reuters,

Japan Seeks Additional Vaccines for COVID-19 Booster Campaign

Japanese Prime Minister Fumio Kishida said Friday his government is seeking to accelerate its COVID-19 booster shots campaign and has reached out to the head of U.S. pharmaceutical company Pfizer to secure additional vaccines.

Kishida told reporters the government has been negotiating to receive 120 million doses of Pfizer’s COVID-19 vaccine ahead of schedule. He said during his call with the company’s CEO, Albert Bourla, he also agreed to purchase two million doses of Pfizer’s oral COVID-19 treatment, Paxlovid.

The government started arrangements Thursday to adjust the timeframe for workers and patients in elder-care facilities to receive booster shots to six months after their second shots. Health officials shortened the original eight-month timeline between initial vaccinations and booster shots after the discovery of the new omicron variant of coronavirus, the virus that causes COVID-19.

Japan has confirmed a handful of omicron variant cases. The Tokyo Metropolitan Government confirmed on Friday that a man in his 20s who attended a soccer match near the capital was found positive for omicron.

Japanese Chief Cabinet Secretary Hirokazu Matsuno also confirmed 70 coronavirus cases have been found at the U.S. Camp Hansen military base in the southern island prefecture of Okinawa.

Matsuno said the Japanese government has urged U.S. officials there to thoroughly quarantine infected persons, identify close contacts at an early stage, and strengthen measures to prevent the spread of infection.

Some information for this report was provided by The Associated Press and Reuters.

After Whistleblower Disclosures, Facebook Faces an Uncertain Future

After internal Facebook documents were shared widely with news organizations, the question remains whether and how Facebook will change. Michelle Quinn reports.

China-Russia Collaboration in Space Poses Challenge for West

China and Russia have begun collaborating on technology to rival the United States’ GPS and European Galileo satellite navigation systems, as the two countries pursue closer military and strategic ties.

Earlier this year, China agreed to host ground monitoring stations for Russia’s GLONASS positioning system on its soil, which improves global range and accuracy but can pose a security risk. In turn, Russia agreed to host ground stations for China’s BeiDou system.

The reciprocal agreement indicates a growing level of trust and cooperation between Moscow and Beijing, says analyst Alexander Gabuev, senior fellow and chair of the Russia in the Asia-Pacific Program at the Carnegie Moscow Center.

“Russia’s schism with the West and deepening confrontation and competition between China and the U.S. as two superpowers is definitely contributing to rapprochement between Moscow and Beijing. There is a natural economic complementarity where Russia has (an) abundance of natural resources, and China has capital and technology to develop those resources. And finally, both are authoritarian states, so they don’t have this allergy when talking domestic political setup, or the poisoning of (Russian opposition leader) Alexi Navalny, or issues like Hong Kong or human rights in Xinjiang,” Gabuev told VOA.

It will take some time for the collaboration on satellite navigation systems to be felt on the ground.

“So far, we have yet to see important results, because in Russia, Russia still relies increasingly on GLONASS but also on GPS. We don’t have major BeiDou-linked projects,” Gabuev added.

Satellites

Satellites are seen as a crucial component of 21st century military power. Last month, Russia tested a missile against one of its own satellites. The U.S. said the resulting debris threatened astronauts on the International Space Station.

“What’s most troubling about that is the danger that it creates for the international community. It undermines strategic stability,” U.S. Secretary of Defense Lloyd Austin told reporters Nov. 17.

Russia, China and the U.S. are among several nations developing hypersonic missiles, which travel through the upper atmosphere at up to five times the speed of sound.

Space treaty

Russian Foreign Minister Sergei Lavrov said the U.S. had failed to engage on a joint Russian-Chinese space treaty.

“They have ignored for many years the initiative of Russia and China to prepare a treaty to prevent an arms race in space. They simply ignore it, insisting instead on developing some sort of universal rules,” Lavrov said.

In an interview June 11 with U.S. broadcaster NBC, Russian President Vladimir Putin said cooperation with Beijing was deepening.

“We have been working and will continue to work with China, which applies to all kinds of programs, including exploring deep space. And I think there is nothing but positive information here. Frankly, I don’t see any contradictions here,” Putin said.

There are limits to Russian and Chinese cooperation, Gabuev said.

“Both Russia and China are religious about their strategic autonomy. There is deep-seated nationalism, there is some level of mistrust and some level of competition in many of those areas where there is seeming complementarity, like space programs. I think that these advances in military technology is happening mostly in parallel, but not jointly.”

India

Gabuev notes that Russia has worked more closely with India than China, including on the development of the joint BrahMos cruise missile system since the 1990s.

“Russia felt secure enough to develop BrahMos missiles together with Indian colleagues. So, this military cooperation between Russia and China is deepening, it’s definitely causing a significant challenge to the West, particularly because it helps the PLA (China’s People’s Liberation Army) to become a really 21st century fighting power and a global military power. But at the same time, we don’t see the depth that exists between, for example, the U.S. and America’s allies,” Gabuev said.

India has also purchased Russia’s S-400 missile defense system, an attempt to counter China’s military might that also risks angering Delhi’s ally, the United States, and an indication of the complexity of strategic relations in a changing world order. 

 

US Permanently Relaxes Restriction on Abortion Pill

The U.S. government on Thursday permanently eased some restrictions on a pill used to terminate early pregnancies, allowing the drug to be sent by mail rather than requiring it to be dispensed in person.

The decision by the Food and Drug Administration comes as the right to obtain an abortion, established in the 1973 Supreme Court ruling Roe v. Wade hangs in the balance.

The medication, generically known as mifepristone, is approved for use up to 10 weeks of pregnancy and is also sometimes prescribed to treat women who are having miscarriages.

“The FDA’s decision will come as a tremendous relief for countless abortion and miscarriage patients,” said Georgeanne Usova, senior legislative counsel at the American Civil Liberties Union.

The restrictions on the pill had been in place since the FDA approved the drug in 2000 and were lifted temporarily by the government earlier this year because of the pandemic. That enabled women to consult health care providers by telemedicine and receive the pills by mail. The FDA’s decision makes that temporary change permanent.

As a result of the FDA rule change, many patients will not need to go to a clinic, medical office or hospital in person to receive the medication but can opt to receive the pill through the mail from a certified prescriber or pharmacy.

The decision will increase access to medication abortion for women in remote and rural areas without providers nearby.

Low-income women who face obstacles reaching clinics such as lack of transportation and inability to take time off work will also gain greater access to the drug.

However, 19 states including Texas have laws that supersede the FDA decision by barring telehealth consultations or the mailing of abortion pills. Women in those states would not be able to make use of the rule change at home but could potentially travel to other states to obtain medication abortion.

States such as California and New York that have sought to strengthen access to abortion may make the drug available to women from other states.

The change is likely to add to the intense U.S. political debate over abortion. Conservative Supreme Court justices indicated in December 1 oral arguments over an abortion ban in Mississippi at 15 weeks of pregnancy that they were open to either gutting Roe or overturning it entirely. A decision is due by the end of June.

The Charlotte Lozier Institute and Susan B. Anthony List, which advocate against abortion, said in a statement that the FDA decision ignored data on complications and put women at risk.

The groups called on the FDA to restore the in-person dispensing requirement and add restrictions.

FDA records show that of the 3.7 million women who took Mifeprex, the branded version of the drug, to terminate a pregnancy between September 2000 and December 2018, 24 died from complications.

Some restrictions remain

The FDA left in place some restrictions, such as the need to use a certified pharmacy and requiring the prescribers to be certified. The ACLU said it was “disappointing that the FDA fell short of repealing all of its medically unnecessary restrictions on mifepristone, and these remaining obstacles should also be lifted.”

The organization sued the U.S. government on behalf of a Hawaii doctor and several professional health care associations in 2017, challenging the restrictions that it said limited access to medication abortion.

Medication abortion involves two drugs, taken over a day or two. The first, mifepristone, blocks the pregnancy-sustaining hormone progesterone. The second, misoprostol, induces uterine contractions.

CDC Advisers Vote to Recommend mRNA COVID-19 Vaccines Over J&J’s

A panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend that Americans choose one of the other two authorized COVID-19 vaccines over Johnson & Johnson’s shot because of the rare but sometimes fatal cases of blood clotting.

The CDC’s Advisory Committee on Immunization Practices voted unanimously on the recommendation. The regulator still needs to sign off on the guidance.

Cases of thrombosis with thrombocytopenia syndrome (TTS), which involves blood clots accompanied by a low level of platelets, have previously been reported in recipients of the J&J vaccine. The highest reporting rates are in women under 50.

The CDC said that the rate of such incidents is higher than previously estimated in both women and men.

At least nine people have died following the blood clotting incidents in the United States, the CDC has said.

Members of the panel also said J&J’s vaccine is less effective in preventing COVID-19 than the other two authorized vaccines.

In a presentation to the committee, a leading J&J vaccine scientist said the vaccine generates a strong and long-lasting immune response with just a single shot.

“In the setting where many people do not return for a second dose or a booster, the durability of the single-shot Johnson & Johnson vaccine as a primary regimen could make a crucial difference in saving lives in the U.S. and around the globe,” J&J’s Dr. Penny Heaton said in the presentation.

J&J’s vaccine uses a technology based on a modified version of an adenovirus to spur immunity in recipients, while the other two authorized vaccines use messenger RNA technology.

J&J’s one-dose vaccine received emergency use authorization in March. In April, U.S. regulators paused administering the vaccine for 10 days to investigate the blood clotting.

A CDC scientist said on Thursday that the rate of deaths from TTS did not decrease after the pause in April.

Fewer Americans have received the J&J shot than the other two vaccines — by a significant margin. Out of more than 200 million fully vaccinated people in the United States, around 16 million received J&J’s vaccine, according to CDC data.

NASA’s Icarus Moment and Trip Through Time in This Week’s Space News

NASA touches the sun and looks to the future by traveling back through time. Plus, Japanese tourists visit the ISS, and a space-travel pioneer’s daughter follows in her father’s flying footsteps. VOA’s Arash Arabasadi brings us the Week in Space.

New Study Says Omicron Variant Grows Faster in Airway Passages

Scientists in Hong Kong say the omicron variant of the coronavirus multiplies much faster in the airway passages, which could explain how the variant is spreading so fast around the globe.

A preliminary report by a team of researchers at the University of Hong Kong says laboratory experiments on tissue samples show omicron grows about 70 times faster than delta in the bronchus, the main tubes from the windpipe to the lungs.

The study also found that omicron grows 10 times slower in lung tissues than the original version, which could indicate a lower chance of a severe illness.

Lead researcher Michael Chan Chi-wai cautions that the severity of disease is not only determined by how quickly the virus replicates, but also by each person’s immune response to the infection, which could evolve into a life-threatening illness.

Dr. Chan adds that “by infecting many more people, a very infectious virus may cause more severe disease and death even though the virus itself may be less pathogenic.”

He says along with recent studies showing omicron can “partially escape immunity” from vaccines and previous infection, “the overall threat from the omicron variant is likely to be very significant.”

Omicron has now been detected in nearly 80 countries since it was first identified in southern Africa back in November.  Indonesia and New Zealand are the latest countries to report their first confirmed case of the virus.

On the vaccine front, an advisory panel with the Centers for Disease Control and Prevention will meet Thursday to discuss imposing limits on the single-shot Johnson & Johnson vaccine because of continued side effects.

The vaccine has been linked to a rare yet serious blood clotting disorder that occurs predominantly among women. At least six women out of the 16 million U.S. citizens who have received the Johnson & Johnson vaccine have been diagnosed with the disorder, including one woman who died.

The blood clotting disorder first emerged in April, soon after the vaccine began to be administered across the U.S., prompting federal health officials to suspend its use for several days while a safety review was conducted. Regulators added a warning about the potential for blood clots on the vaccine’s label, but concluded that its benefits outweighed the risks.

The Johnson & Johnson vaccine trails well behind the two-dose Pfizer and Moderna vaccines in terms of demand, both as an initial dose or a booster shot.

Some information for this report came from Reuters. 

‘Flash Mob-Style’ Thefts Challenge Stores and Holiday Shoppers

A series of “flash mob-style” thefts in U.S. stores this holiday season is leading to higher security and a lot of finger-pointing. Matt Dibble reports. Michelle Quinn contributed to this report.

End of an Era: Airbus Delivers Last A380 Superjumbo to Emirates 

Airbus is set to deliver the final A380 superjumbo to Dubai’s Emirates on Thursday, marking the end of a 14-year run that gave Europe an instantly recognized symbol across the globe but failed to fulfil the commercial vision of its designers. 

 

Production of the world’s largest airliner — capable of seating 500 people on two decks together with perks like showers in first class — has ended after 272 were built compared with the 1,000 or more once predicted. 

 

Airbus, a planemaking conglomerate drawn together from separate entities in Britain, France, Germany and Spain to carry out their brainchild of mega-jets to beat congestion, pulled the plug in 2019 after airlines went for smaller, leaner models. 

 

Thursday’s handover is expected to be low key, partly because of COVID restrictions and also because Airbus is these days focusing its PR on environmental benefits of smaller jets. 

 

That’s in stark contrast to the spectacular light show that revealed the new behemoth in front of European leaders in 2005. 

 

Emirates is by far the largest buyer and still believes in the superjumbo’s ability to lure passengers. Even though no more A380s will be built, it will keep flying them for years. Many airlines disagree and have axed the A380 during the pandemic. 

 

Airline president Tim Clark refuses to bow to sceptics who say the days of spacious four-engined jets like the A380 are numbered as an airline seat becomes a commodity like any other. 

 

“I don’t share that view at all … And I still believe there is a place for the A380,” Clark recently told reporters. 

 

“Technocrats and accountants said it was not fit for purpose … That doesn’t resonate with our travelling public. They absolutely love that airplane,” he said. 

 

Shower talks

 The A380’s demise left deserted one of the world’s largest buildings, a 122,500-square-metre assembly plant in Toulouse. 

Airbus plans to use part of it to build some of the bread-and-butter narrowbody models that dominate sales like a deal with Qantas announced earlier on Thursday. 

But it is in Hamburg that some of the most striking features of the A380 evolved. 

 

Clark recalled how he huddled with Airbus developers in northern Germany to persuade Airbus chiefs in France to pay for the engineering needed to make in-flight showers a reality. 

 

“There was a lot of arm-folding and my friends in France were a little circumspect,” Clark said. 

 

“I had to sit with friends in the development unit in Hamburg having to build the showers, and then asked Toulouse management to see how it could be done, and so they bought in.” 

 

That innovation generated headlines but did not translate into sales needed to keep the A380 going. 

 

The plane was designed in the 1990s when travel demand was soaring and China offered seemingly unlimited potential. 

 

By the time the first delivery came in 2007, the plane was more than two years late. And when Emirates got its first A380 a year later, the emerging financial crisis was already forcing analysts to trim their forecasts for the biggest jets. 

 

Boeing was meanwhile capturing orders for a revolutionary new 787 Dreamliner, to be followed by the Airbus A350. 

 

“There was a slowing down of appetite and enthusiasm. We didn’t share that view; we put this great [A380] aircraft to work,” Clark said on the sidelines of an airlines meeting. 

 

“We have what I think is one of the most beautiful aircraft ever flown.” 

Israel to Donate 1 Million COVID Vaccines to African Nations

The Israeli government on Wednesday said it was donating 1 million coronavirus vaccines to the U.N.-backed COVAX program.

The Foreign Ministry said the AstraZeneca vaccines would be transferred in the coming weeks, a decision that was part of Israel’s strengthening ties with the African countries.

“I am delighted that Israel can contribute and be a partner in eradicating the pandemic around the world,” said Foreign Minister Yair Lapid.

The announcement said the vaccines would reach close to a quarter of African countries, though it did not provide a list. Israel has close ties with a number of African nations, including Kenya, Uganda and Rwanda. Israel also established relations with Sudan last year as part of a series of U.S.-brokered accords.

COVAX is a global initiative that aims to provide coronavirus vaccines to poorer nations. Wealthier countries have acquired the most of the world’s vaccine supplies, causing vast inequality in access to jabs.

Israel was one of the first countries to vaccinate its population. Early this year, it came under criticism for not sharing enough of its supplies with the Palestinians.

Since then, Israel has vaccinated tens of thousands of Palestinians who work in Israel and its settlements, and the Palestinians have procured vaccines from COVAX and other sources. 

 

US CDC: Omicron Now About 3% of All COVID-19 Cases

The White House COVID-19 Response team Wednesday said early data indicates the omicron coronavirus variant is spreading in the U.S., but current vaccine boosters appear to be effective in fighting it.

CDC Director Rochelle Walensky said the variant is in 36 U.S. states and accounts for 3% of all U.S. COVID-19 cases, though it is higher in some areas, such as New York and New Jersey, where it may account for as much 13% of cases.

Walensky said while the vast majority — 96% — of U.S. cases are still caused by the delta variant, she said early data show the omicron variant spreads faster than delta, with cases doubling in about two days.

Walensky, along with White House Chief Medical Adviser Anthony Fauci and COVID-19 Response coordinator Jeff Zients, cited data showing being fully vaccinated along with a booster shot is the best way to fight off the new variant.

“Our booster vaccine regimens work against omicron,” Fauci said. “At this point, there is no need for a variant-specific booster.”

Walensky cited recent data from U.S. nursing homes showing unvaccinated or fully vaccinated residents without boosters were 10 times more likely to contract COVID-19 than residents fully vaccinated with boosters. Fauci cited the most real-world studies showing boosters can increase anti-body protection against omicron by as much as 35 times.

Zients cited CDC statistics showing an unvaccinated person is eight times more likely to be hospitalized and 14 times more likely to die from COVID-19 than a fully vaccinated person. He said a new study from the Yale University of Public Health shows the U.S. vaccination program prevented 10.3 million hospitalizations and saved 1.1 million lives.

The COVID-19 response coordinator said 14 million people received booster shots in the first two weeks of December, with 26 million total shots in arms during the same period. In total, the team reports more than 200 million U.S. residents are now fully vaccinated, and more than 55 million have received booster shots.

Some information in this report was provided by the Reuters news agency.